What Is a Korea License Holder (KLH)? Independent vs. Distributor Models

The Decision That Locks Your Market for Years

A Korea License Holder (KLH) — formally an Importer-Approval Holder under MFDS terminology — is the legal entity that holds the import license and bears regulatory responsibility for a foreign-made device in Korea. Every imported device has exactly one KLH at any given time. The choice between distributor-tied and independent KLH structures is one of the most consequential early decisions for a manufacturer entering Korea, because changing the KLH later is administratively expensive and commercially disruptive.

Distributor-as-KLH: The Default That Catches Manufacturers

The conventional model is for the Korean distributor to also serve as the KLH. The distributor handles imports, holds the license, manages KGMP audits, files post-market reports. From the foreign manufacturer's perspective, it is one contract, one relationship, one invoice.

This is convenient until any of these happen:

• The manufacturer wants to switch distributors.
• The manufacturer wants to add a second distributor for a different region or channel.
• The distributor underperforms but holds the license.
• The manufacturer wants to negotiate directly with hospitals or a large IDN.

When the KLH is the distributor, switching distributors means re-registering the device under the new license holder, which can take 3–6 months and re-opens classification, KGMP, and labeling reviews. During that window the device cannot be sold by the new partner.

We have seen manufacturers lose 6–12 months of revenue on a distributor switch because the license was held hostage by the prior partner.

Independent KLH: A Firewall Between License and Commercial

An independent KLH is a regulatory entity (often a specialist firm) that holds the license but does not distribute or sell the device commercially. The manufacturer keeps the license on its own terms; distributors are pure commercial partners.

The structure looks like this:

Manufacturer (overseas)
   │
   │ regulatory authorization
   ▼
Independent KLH (Korea) ◄── license holder + KGMP + post-market reporting
   │
   │ supply / appointment
   ▼
Distributor A, Distributor B, hospital direct, etc. ◄── pure commercial

The independent KLH does not compete with distributors. Its only product is regulatory custody.

When Each Model Fits

Situation	Recommended KLH structure
Single trusted distributor with a long, exclusive relationship	Distributor-as-KLH is acceptable
Multiple distributors planned (by region, channel, or product line)	Independent KLH required
Distributor is being evaluated (less than 12 months of relationship)	Independent KLH (preserve flexibility)
Manufacturer plans direct sales to large hospital systems	Independent KLH required
Manufacturer expects acquisition or IPO in 24–36 months	Independent KLH (registration becomes a transferable asset)
Single SKU, niche specialty, single distributor for 5+ year term	Distributor-as-KLH is the cheapest option

The Switchover: How Hard Is It Really?

Switching from a distributor-tied KLH to an independent KLH is technically a change of importer, requiring:

1. A new application under the new KLH
2. A 30–60 day MFDS review for the change
3. Updated labeling reflecting the new KLH name
4. KGMP transfer or re-audit, depending on the original certificate scope
5. Inventory handling — old labels must clear or be relabeled

The total switchover runs 3–4 months when it goes smoothly, 6+ months when the prior distributor is non-cooperative. The Seamless Distributor Transition solution exists specifically to compress this window and isolate the legal complexity from the commercial sales pipeline.

Cost Comparison

A common objection to independent KLH is the cost. The maths usually does not favor distributor-as-KLH once you model honestly.

Distributor-as-KLH: included in the distribution margin. Looks free.

• True cost: 2–8 percentage points of margin embedded in the distribution agreement, plus opportunity cost of switching difficulty.

Independent KLH: explicit annual fee, typically ₩30M–₩80M per year depending on product complexity and number of SKUs.

• True cost: explicit and bounded.

For a product doing ₩5B/year in Korean revenue, the independent KLH fee is well under 2% of revenue and buys distributor flexibility. For a product doing ₩200M/year, distributor-as-KLH may genuinely be the right answer.

Three Questions Before You Decide

1. What is the probability we change distributors in the next 36 months? If above 30%, choose independent.
2. Do we expect direct-to-hospital sales? If yes, choose independent.
3. Is the device the distributor's flagship product, or one of many? If one of many, the distributor's incentive to invest in regulatory maintenance is weak — choose independent.

Where Leanabl Plugs In

Leanabl operates as an independent KLH through the KLH Service for manufacturers who want regulatory custody separated from commercial distribution. For manufacturers already locked into distributor-as-KLH and wanting to switch, the Seamless Distributor Transition solution carries the switchover. Both pair with Korea License Maintenance for the ongoing post-issuance work.